Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone

Scleromyxedema is a rare and distinctive variant of cutaneous mucinoses of unknown etiology. It is presenting with generalized papular eruption and sclerodermoid induration. Numerous treatment modalities have been reported to produce partial or permanent responses. This study reports on a case of sc...

Full description

Bibliographic Details
Main Authors: Sara Saniee, Ghazaleh Davarnia
Format: Article
Language:English
Published: Karger Publishers 2016-11-01
Series:Case Reports in Dermatology
Subjects:
Online Access:http://www.karger.com/Article/FullText/452319
_version_ 1819156606594580480
author Sara Saniee
Ghazaleh Davarnia
author_facet Sara Saniee
Ghazaleh Davarnia
author_sort Sara Saniee
collection DOAJ
description Scleromyxedema is a rare and distinctive variant of cutaneous mucinoses of unknown etiology. It is presenting with generalized papular eruption and sclerodermoid induration. Numerous treatment modalities have been reported to produce partial or permanent responses. This study reports on a case of scleromyxedema without paraproteinemia in a subject who experienced a partial response to thalidomide and prednisolone.
first_indexed 2024-12-22T15:55:33Z
format Article
id doaj.art-8a72f3737c4b46de92ffebe159867a71
institution Directory Open Access Journal
issn 1662-6567
language English
last_indexed 2024-12-22T15:55:33Z
publishDate 2016-11-01
publisher Karger Publishers
record_format Article
series Case Reports in Dermatology
spelling doaj.art-8a72f3737c4b46de92ffebe159867a712022-12-21T18:20:48ZengKarger PublishersCase Reports in Dermatology1662-65672016-11-018332733210.1159/000452319452319Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and PrednisoloneSara SanieeGhazaleh DavarniaScleromyxedema is a rare and distinctive variant of cutaneous mucinoses of unknown etiology. It is presenting with generalized papular eruption and sclerodermoid induration. Numerous treatment modalities have been reported to produce partial or permanent responses. This study reports on a case of scleromyxedema without paraproteinemia in a subject who experienced a partial response to thalidomide and prednisolone.http://www.karger.com/Article/FullText/452319ScleromyxedemaParaproteinemiaMucinosesThalidomide
spellingShingle Sara Saniee
Ghazaleh Davarnia
Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
Case Reports in Dermatology
Scleromyxedema
Paraproteinemia
Mucinoses
Thalidomide
title Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
title_full Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
title_fullStr Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
title_full_unstemmed Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
title_short Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
title_sort scleromyxedema without paraproteinemia treatment with thalidomide and prednisolone
topic Scleromyxedema
Paraproteinemia
Mucinoses
Thalidomide
url http://www.karger.com/Article/FullText/452319
work_keys_str_mv AT sarasaniee scleromyxedemawithoutparaproteinemiatreatmentwiththalidomideandprednisolone
AT ghazalehdavarnia scleromyxedemawithoutparaproteinemiatreatmentwiththalidomideandprednisolone